Vojdani A, Choppa P C, Tagle C, Andrin R, Samimi B, Lapp C W
Immunosciences Laboratory, Beverly Hills, CA 90211, USA.
FEMS Immunol Med Microbiol. 1998 Dec;22(4):355-65. doi: 10.1111/j.1574-695X.1998.tb01226.x.
Mycoplasma fermentans and other Mycoplasma species are colonizers of human mucosal surfaces and may be associated with human immunodeficiency virus infection. While many infectious agents have been described in different percentages of patients with Chronic Fatigue Syndrome (CFS), little is known about the prevalence of mycoplasmas and especially M. fermentans in CFS patients. A polymerase chain reaction (PCR)-based assay was used to detect Mycoplasma genus and M. fermentans genomes in peripheral blood mononuclear cells (PBMC) of CFS patients. Blood was collected from 100 patients with CFS and 50 control subjects. The amplified products of 717 bp of Mycoplasma genus, and 206 bp of M. fermentans were detected in DNA purified from blood samples in 52% and 34% of CFS samples, respectively. In contrast, these genomes were found in only 14% and 8% of healthy control subjects respectively (P < 0.0001). All samples were confirmed by Southern blot with a specific probe based on internal sequences of the expected amplification product. Several samples, which were positive for Mycoplasma genus, were negative for M. fermentans indicating that other Mycoplasma species are involved. A quantitative PCR was developed to determine the number of M. fermentans genome copies present in 1 microg of DNA for controls and CFS patients. Mycoplasma copy numbers ranging from 130 to 880 and from 264 to 2400 were detected in controls and CFS positive subjects, respectively. An enzyme immunoassay was applied for the detection of antibodies against p29 surface lipoprotein of M. fermentans to determine the relationship between M. fermentans genome copy numbers and antibody levels. Individuals with high genome copy numbers exhibited higher IgG and IgM antibodies against M. fermentans specific peptides. Isolation of this organism by culture from clinical specimens is needed in order to demonstrate specificity of signal detected by PCR in this study.
发酵支原体及其他支原体属是人类黏膜表面的定植菌,可能与人类免疫缺陷病毒感染有关。虽然在不同比例的慢性疲劳综合征(CFS)患者中已发现多种感染因子,但对于支原体尤其是发酵支原体在CFS患者中的流行情况知之甚少。采用基于聚合酶链反应(PCR)的检测方法,检测CFS患者外周血单个核细胞(PBMC)中的支原体属及发酵支原体基因组。采集了100例CFS患者和50例对照者的血液。在分别从CFS样本的血液中纯化的DNA中,检测到支原体属717 bp的扩增产物以及发酵支原体206 bp的扩增产物,比例分别为52%和34%。相比之下,这些基因组在健康对照者中分别仅为14%和8%(P < 0.0001)。所有样本均通过基于预期扩增产物内部序列的特异性探针进行Southern印迹法确认。几个支原体属呈阳性的样本,发酵支原体呈阴性,表明涉及其他支原体物种。开发了一种定量PCR方法,以确定对照者和CFS患者每1 μg DNA中存在的发酵支原体基因组拷贝数。在对照者和CFS阳性受试者中分别检测到130至880以及264至2400的支原体拷贝数。应用酶免疫测定法检测针对发酵支原体p29表面脂蛋白的抗体,以确定发酵支原体基因组拷贝数与抗体水平之间的关系。基因组拷贝数高的个体针对发酵支原体特异性肽表现出更高的IgG和IgM抗体。为了证明本研究中PCR检测到的信号的特异性,需要从临床标本中通过培养分离该生物体。